Evidence map›Paper›PMID 36073822›Full record

ArticleMicrobiology spectrum2022

Dual-Targeting Polymer Nanoparticles Efficiently Deliver DNA Vaccine and Induce Robust Prophylactic Immunity against Spring Viremia of Carp Virus Infection.

Chen Zhang, Peng-Qi Zhang, Sheng Guo, Zhao Zhao, Gao-Xue Wang, Bin Zhu

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Chen ZhangCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, People's Republic of China.
Peng-Qi ZhangCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, People's Republic of China.
Sheng GuoCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, People's Republic of China.
Zhao ZhaoCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, People's Republic of China.
Gao-Xue WangCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, People's Republic of China.
Bin ZhuCollege of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, People's Republic of China.ORCID 0000-0001-5702-524X
Northwest A&F University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spring viremia of carp virus (SVCV) is highly contagious and lethal to most cyprinid fish, causing serious economic losses to the carp aquaculture industry. Although DNA vaccines can generate long-term humoral and cellular immune responses, which provide protective immunity against SVCV, the major drawback of DNA vaccines is their low immunogenicity in clinical tests. Here, we construct a dual-targeted polymer DNA vaccine delivery platform (MCS-PCHG) by using mannosylated chitosan to encapsulate the poly(d,l-lactide-

Indexed as

CarpsChitosanFish DiseasesNanoparticlesRhabdoviridae InfectionsVaccines, DNAAnimalsAntibodies, NeutralizingImmunoglobulin MMannosePolylactic Acid-Polyglycolic Acid CopolymerPolymersViremiaAntibodies, NeutralizingChitosanImmunoglobulin MMannosePolylactic Acid-Polyglycolic Acid CopolymerPolymersVaccines, DNAantigen presentinganti-SVCV immunityDNA vaccinepolymer nanovaccinespring viremia of carp virusSVCVtargeted delivery

Identifiers

PMID36073822
PMCPMC9603200
OpenAlexW4294991179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.